Cargando…
The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling
BACKGROUND: Characterization of molecular mechanisms underpinning development of pancreatic ductal adenocarcinoma (PDAC) may lead to the identification of novel therapeutic targets and biomarkers. SgK223, also known as Pragmin, is a pseudokinase and scaffolding protein closely related to SgK269/PEAK...
Autores principales: | Tactacan, Carole M., Phua, Yu Wei, Liu, Ling, Zhang, Luxi, Humphrey, Emily S., Cowley, Mark, Pinese, Mark, Biankin, Andrew V., Daly, Roger J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517651/ https://www.ncbi.nlm.nih.gov/pubmed/26215634 http://dx.doi.org/10.1186/s12943-015-0412-3 |
Ejemplares similares
-
Structure of SgK223 pseudokinase reveals novel mechanisms of homotypic and heterotypic association
por: Patel, Onisha, et al.
Publicado: (2017) -
Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
por: Raivola, Juuli, et al.
Publicado: (2019) -
RON is not a prognostic marker for resectable pancreatic cancer
por: Tactacan, Carole M, et al.
Publicado: (2012) -
Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain
por: Virtanen, Anniina T., et al.
Publicado: (2023) -
Structure of a pseudokinase domain switch that controls oncogenic activation of Jak kinases
por: Toms, Angela V., et al.
Publicado: (2013)